<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02702687</url>
  </required_header>
  <id_info>
    <org_study_id>2014-3257</org_study_id>
    <secondary_id>1R01HL128260-01</secondary_id>
    <nct_id>NCT02702687</nct_id>
  </id_info>
  <brief_title>Childhood Asthma Perception Study</brief_title>
  <acronym>CAPS</acronym>
  <official_title>Childhood Asthma Perception Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albert Einstein College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Albert Einstein College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial will include Latino and Black adolescents with asthma ages&#xD;
      10-17 years old and their caregivers. Participants will be recruited from clinics in the&#xD;
      Bronx, NY. The primary aims are to examine the efficacy of peak expiratory flow (PEF)&#xD;
      prediction with feedback versus control feedback on 1) under-perception of asthma symptoms 2)&#xD;
      controller medication adherence and 3) asthma control and emergency health care use. These&#xD;
      aims will be examined across a 1-year follow-up. An exploratory aim examines the hypothesized&#xD;
      pathway that the PEF intervention reduces under-perception of symptoms, shifts illness&#xD;
      representations toward the professional model and increases adolescents' and parents' asthma&#xD;
      management self-efficacy, resulting in greater medication adherence and improved asthma&#xD;
      control.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Under-perception of asthma symptoms in children is a major risk factor for emergency&#xD;
      department visits, hospitalizations, and near-fatal/fatal asthma attacks. Puerto Rican and&#xD;
      Black children have greater asthma morbidity and mortality rates than all other racial/ethnic&#xD;
      groups. Interventions targeting asthma symptom perception and medication adherence may help&#xD;
      close this asthma health disparities gap.&#xD;
&#xD;
      The baseline visit for all families consists of standardized asthma education followed by 3&#xD;
      weeks of PEF prediction without feedback using a programmable, electronic spirometer.&#xD;
      Participants then will be randomized to intervention group or control feedback group and&#xD;
      receive a brief feedback session. For the next 6 weeks, all adolescents will predict their&#xD;
      PEF, which will be locked in before blowing into the device. Families will return at&#xD;
      mid-intervention and post-intervention to receive feedback sessions. All adolescents will&#xD;
      play an interactive asthma educational game to reinforce the baseline asthma education. At&#xD;
      the post-intervention visit, the spirometer will be reprogrammed for the next 4 weeks. These&#xD;
      symptom perception data will be downloaded at 1-month post-intervention. Controller&#xD;
      medication adherence will be monitored by electronic devices. Post-intervention sessions will&#xD;
      take place at 3, 6, 9, and 12 months to collect adherence data and conduct spirometry.&#xD;
      Physicians will be blinded to group assignment and rate asthma severity using national&#xD;
      guidelines. A 12-month retrospective medical record abstraction will compare emergency health&#xD;
      care use for asthma between groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Asthma Symptom Perception with AM2 as percentage of guesses in the Under-Perception zone</measure>
    <time_frame>Change from Pre-intervention to 12-month-follow-up (15 months)</time_frame>
    <description>The percentage of times a child under-perceives the severity of asthma symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Asthma Illness Representation Scale (AIRS)</measure>
    <time_frame>Change from Pre-intervention to 12-month-follow-up (15 months)</time_frame>
    <description>37-item scale measuring risk factors for the underutilization of controller medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Management Self-Efficacy (ASE) scale: Parent and child versions</measure>
    <time_frame>Change from Pre-intervention to 12-month-follow-up (15 months)</time_frame>
    <description>13-item scale measures parent's confidence in their ability to help manage child's asthma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric Asthma Quality of Life Questionnaire (PAQLQ)</measure>
    <time_frame>Change from Pre-intervention to 12-month-follow-up (15 months)</time_frame>
    <description>23-item self report questionnaire assessing child's overall functioning in relation to asthma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence - percentage of total doses taken per day/prescribed per day</measure>
    <time_frame>Change from Pre-intervention to 12-month-follow-up (15 months)</time_frame>
    <description>Self report of daily medication use, in relation to the prescribed use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Care Use - EMR review of asthma-related ED visits and hospitalizations</measure>
    <time_frame>Change from Pre-intervention to 12-month-follow-up (15 months)</time_frame>
    <description>Quantity of asthma-related emergency visits throughout the duration of the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Control Test (C-ACT)</measure>
    <time_frame>Change from Pre-intervention to 12-month-follow-up (15 months)</time_frame>
    <description>Self-report questionnaire for adolescents and parents</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">363</enrollment>
  <condition>Asthma</condition>
  <condition>Childhood Asthma</condition>
  <arm_group>
    <arm_group_label>PEF Feedback</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will have 9 visits across 15 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Feedback</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will have 9 visits across 15 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PEF Feedback</intervention_name>
    <description>Intervention group will receive PEF feedback and verbal feedback sessions across 3 feedback visits and asthma education.</description>
    <arm_group_label>PEF Feedback</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control Feedback</intervention_name>
    <description>Control feedback group will receive feedback consisting of standardized messages and have 3 control feedback visits and asthma education.</description>
    <arm_group_label>Control Feedback</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  10-17 years of age&#xD;
&#xD;
          -  Diagnosis of asthma (in medical record)&#xD;
&#xD;
          -  Report of breathing problems within the past 12 months&#xD;
&#xD;
          -  Prescribed a controller medication for asthma&#xD;
&#xD;
          -  At least one parent self-identifies as Latino or Black&#xD;
&#xD;
          -  The participating parent has primary or at least equal responsibility for the&#xD;
             adolescent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive learning disability (parent report)&#xD;
&#xD;
          -  No prescription for asthma controller medication&#xD;
&#xD;
          -  Inability to perform acceptable PEF blows&#xD;
&#xD;
          -  Race/ethnicity other than Latino or Black&#xD;
&#xD;
          -  Other significant pulmonary conditions (cystic fibrosis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Feldman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jacobi Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 25, 2016</study_first_submitted>
  <study_first_submitted_qc>March 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2016</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Childhood Asthma</keyword>
  <keyword>Bronchial Diseases</keyword>
  <keyword>Immune System Diseases</keyword>
  <keyword>Lung Diseases</keyword>
  <keyword>Lung Diseases, Obstructive</keyword>
  <keyword>Respiratory Tract Diseases</keyword>
  <keyword>Peak Flow Meter</keyword>
  <keyword>Symptom Perception</keyword>
  <keyword>Illness Representation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 12, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT02702687/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

